Crinetics Pharmaceuticals Inc (CRNX)
59.75
+0.59
(+1.00%)
USD |
NASDAQ |
Nov 07, 16:00
59.92
+0.17
(+0.28%)
After-Hours: 20:00
Crinetics Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 4.722M |
| June 30, 2023 | 4.834M |
| March 31, 2023 | 4.285M |
| Date | Value |
|---|---|
| December 31, 2022 | 4.737M |
| September 30, 2022 | 5.106M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
4.285M
Minimum
Mar 2023
5.106M
Maximum
Sep 2022
4.737M
Average
4.737M
Median
Dec 2022
Revenue (TTM) Benchmarks
| PTC Therapeutics Inc | 900.45M |
| Zevra Therapeutics Inc | 23.99M |
| Clearside Biomedical Inc | 7.524M |
| Biomea Fusion Inc | -- |
| NovaBay Pharmaceuticals Inc | 12.02M |